Tag: Neratinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Neratinib

Prospera Financial Services Inc Buys 13744 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI)

Added to Collection on: 2022-11-14 17:16:38

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Puma Biotechnology
Neratinib
Puma
Short
Puma Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
Brandywine Global Investment Management LLC Lowers Position in Puma Biotechnology ...

Added to Collection on: 2022-11-28 11:34:42

Tags for this article:

Chemical compounds
Organic compounds
Armoured fighting vehicles
Puma Biotechnology
Puma
Neratinib
Short
Puma Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at ... - MarketScreener

Added to Collection on: 2022-12-08 16:48:58

Tags for this article:

Chemical compounds
Organic compounds
Cancer
Genentech
Aromatic amines
Chloroarenes
Trastuzumab emtansine
Neratinib
Breast cancer
HER2/neu
Mertansine
Oncology
Puma Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
Reviewing Puma Biotechnology (NASDAQ:PBYI) & Eledon Pharmaceuticals (NASDAQ:ELDN)

Added to Collection on: 2022-12-28 06:27:32

Tags for this article:

Chemical compounds
Organic compounds
Companies
Puma Biotechnology
Pharmaceutical industry in China
Pfizer
Neratinib
Puma
Eledon Pharmaceuticals Inc.
Puma Biotechnology Inc.
Novus Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology (NASDAQ:PBYI) Share Price Crosses Above 200-Day Moving Average of $3.18

Added to Collection on: 2023-01-03 07:28:22

Tags for this article:

Finance
Companies
Money
Primary dealers
Puma Biotechnology
Puma
Short
BNP Paribas
Neratinib
Stock
UBS
Puma Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology, Inc. (NASDAQ:PBYI) CEO Sells $113867.38 in Stock

Added to Collection on: 2023-01-07 16:17:23

Tags for this article:

Finance
Economy
Chemical compounds
Puma Biotechnology
Financial markets
Puma
Neratinib
Stock market
Short
Stock
BNP Paribas
Puma Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology Releases Up - GuruFocus.com

Added to Collection on: 2023-01-09 14:04:50

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
RTT
Genentech
Chloroarenes
Neratinib
Nitriles
Pyridines
Trastuzumab
Puma Biotechnology
HER2/neu
Puma Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology to Join Russell 3000 Index - Yahoo Finance

Added to Collection on: 2024-05-28 13:33:05

Tags for this article:

Immunology
Puma Biotechnology
Neratinib
Trastuzumab
Russell Indexes
RUSSELL 2000 PRICE RETURN USD
Russell 1000 Price Return USD
United States
Puma Biotechnology Inc.
Russell 3000 Price Return USD
Russell Investments

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 ...

Added to Collection on: 2025-02-13 21:19:16

Tags for this article:

Breast cancer
Cancer treatments
Immunology
Chloroarenes
Neratinib
Nitriles
Trastuzumab
HER2
Puma Biotechnology
Trastuzumab emtansine
Xavier Pivot

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology Q4 2024 Earnings Call Scheduled for February 27 - Stock Titan

Added to Collection on: 2025-02-13 21:18:00

Tags for this article:

Chloroarenes
Cancer treatments
Neratinib
Nitriles
Quinolines
Puma Biotechnology
HER2
Puma
Trastuzumab
Alisertib
Breast cancer

Click the tags to see associated articles and topics

View Article Details